Citadel Advisors - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 2 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$15,000
-48.3%
29,572
-6.0%
0.00%
Q4 2018$29,000
+20.8%
31,456
+88.1%
0.00%
Q2 2018$24,000
-36.8%
16,722
-10.6%
0.00%
Q4 2017$38,00018,7110.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 169,901$411,0000.03%
Benin Management CORP 14,300$35,0000.01%
Northeast Financial Consultants Inc 15,000$36,0000.01%
WEDBUSH SECURITIES INC 25,500$62,0000.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 49,167$119,0000.00%
Renaissance Technologies 344,299$833,0000.00%
WELLS FARGO & COMPANY/MN 8,238$20,0000.00%
NORTHERN TRUST CORP 47,859$116,0000.00%
GROUP ONE TRADING, L.P. 28$00.00%
GEODE CAPITAL MANAGEMENT, LLC 146,083$353,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders